Stock Track | BEIGENE Plummets 7.45% in Pre-market on Earnings Caution and Below-Guide Revenue Outlook

Stock Track

02/26

BEIGENE LTD's American depositary shares experienced a significant pre-market plummet of 7.45% on Thursday, reflecting heavy selling pressure at the market open.

The sharp decline comes as the innovative drug company is scheduled to release its 2025 financial report, with investors exhibiting caution and negative expectations ahead of the earnings announcement. Market sentiment was further dampened by the company's 2026 revenue guidance, which fell below analyst estimates, contributing to the sell-off.

The stock's drop also reflected broader weakness in the pharmaceutical sector, where innovative drug stocks led market declines during the session. As a leading component of several pharmaceutical ETFs, BEIGENE's performance is closely watched by investors tracking the healthcare industry's transition from research and development to commercialization.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1181796814"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1181796814\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1181796814?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-26 23:33","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1181796814","market":"hk","top_or_hot":-1,"title":"Stock Track | BEIGENE Plummets 7.45% in Pre-market on Earnings Caution and Below-Guide Revenue Outlook","media":"Stock Track","content":"<p>BEIGENE LTD's American depositary shares experienced a significant pre-market plummet of 7.45% on Thursday, reflecting heavy selling pressure at the market open.</p><p>The sharp decline comes as the innovative drug company is scheduled to release its 2025 financial report, with investors exhibiting caution and negative expectations ahead of the earnings announcement. Market sentiment was further dampened by the company's 2026 revenue guidance, which fell below analyst estimates, contributing to the sell-off.</p><p>The stock's drop also reflected broader weakness in the pharmaceutical sector, where innovative drug stocks led market declines during the session. As a leading component of several pharmaceutical ETFs, BEIGENE's performance is closely watched by investors tracking the healthcare industry's transition from research and development to commercialization.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | BEIGENE Plummets 7.45% in Pre-market on Earnings Caution and Below-Guide Revenue Outlook</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | BEIGENE Plummets 7.45% in Pre-market on Earnings Caution and Below-Guide Revenue Outlook\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-02-26 23:33</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>BEIGENE LTD's American depositary shares experienced a significant pre-market plummet of 7.45% on Thursday, reflecting heavy selling pressure at the market open.</p><p>The sharp decline comes as the innovative drug company is scheduled to release its 2025 financial report, with investors exhibiting caution and negative expectations ahead of the earnings announcement. Market sentiment was further dampened by the company's 2026 revenue guidance, which fell below analyst estimates, contributing to the sell-off.</p><p>The stock's drop also reflected broader weakness in the pharmaceutical sector, where innovative drug stocks led market declines during the session. As a leading component of several pharmaceutical ETFs, BEIGENE's performance is closely watched by investors tracking the healthcare industry's transition from research and development to commercialization.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ONC","symbol_name":"百济神州","start_time":0,"source_url":"","article_id":"1181796814","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1181796814","pubTimestamp":1772119992,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"BEIGENE LTD's American depositary shares experienced a significant pre-market plummet of 7.45% on Thursday, reflecting heavy selling pressure at the market open.The sharp decline comes as the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ONC":"百济神州"},"translate_title":"个股追踪|百济神州盘前暴跌7.45%因财报谨慎及营收前景低于指引","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ONC":1},"content_text":"BEIGENE LTD's American depositary shares experienced a significant pre-market plummet of 7.45% on Thursday, reflecting heavy selling pressure at the market open.The sharp decline comes as the innovative drug company is scheduled to release its 2025 financial report, with investors exhibiting caution and negative expectations ahead of the earnings announcement. Market sentiment was further dampened by the company's 2026 revenue guidance, which fell below analyst estimates, contributing to the sell-off.The stock's drop also reflected broader weakness in the pharmaceutical sector, where innovative drug stocks led market declines during the session. As a leading component of several pharmaceutical ETFs, BEIGENE's performance is closely watched by investors tracking the healthcare industry's transition from research and development to commercialization.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}